Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 33
2014 2
2015 9
2016 9
2017 18
2018 13
2019 13
2020 6
2021 11
2022 11
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31643391

101 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib.
[No authors listed] [No authors listed] 2017 May 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 May 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643391 Free Books & Documents. Review.
Tepotinib.
[No authors listed] [No authors listed] 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 37782745 Free Books & Documents. Review.
Capmatinib.
[No authors listed] [No authors listed] 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Sep 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 37782740 Free Books & Documents. Review.
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.
Ando C, Ichihara E, Nishi T, Morita A, Hara N, Takada K, Nakasuka T, Watanabe H, Kano H, Nishii K, Makimoto G, Kondo T, Ninomiya K, Fujii M, Kubo T, Ohashi K, Matsuoka KI, Hotta K, Tabata M, Maeda Y, Kiura K. Ando C, et al. Cancer Sci. 2023 Nov;114(11):4343-4354. doi: 10.1111/cas.15958. Epub 2023 Sep 15. Cancer Sci. 2023. PMID: 37715310 Free PMC article.
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results.
Lococo F, Cancellieri A, Chiappetta M, Leonetti A, Cardillo G, Zanelli F, Mangiameli G, Toschi L, Guggino G, Romano FJ, Leuzzi G, Proto C, Spaggiari L, De Marinis F, Vita E, Ampollini L, Margaritora S, Tiseo M, Bria E. Lococo F, et al. Clin Lung Cancer. 2023 Jul;24(5):467-473. doi: 10.1016/j.cllc.2023.03.008. Epub 2023 Mar 20. Clin Lung Cancer. 2023. PMID: 37061413 Free article.
Alectinib - induced acute renal failure.
Prado-Mel E, Ciudad-Gutiérrez P, Sánchez-Martín A, Martín LA. Prado-Mel E, et al. J Oncol Pharm Pract. 2023 Apr 6:10781552231167808. doi: 10.1177/10781552231167808. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37021408
101 results